Session Information
AABB Annual Meeting and CTTXPO 2012
Click here to go to the previous page
Molecular Dry Matching of Red Cells to Curtail Immune Hazards
Track : TC - Technical/Clinical
Program Code: 9310-TC
Date: Monday, October 8, 2012
Time: 10:30 AM to 12:00 PM  EST
Location: 153A-C
DIRECTOR :
Bill Flegel, MD, Chief, Laboratory Services Section, National Institutes of Health
MODERATOR :
Gregory Denomme, PhD, FCSMLS(D), Director of Immunohematology & Transfusion Services, BloodCenter of Wisconsin
SPEAKER (S):
Gregory Denomme, PhD, FCSMLS(D), Director of Immunohematology & Transfusion Services, BloodCenter of Wisconsin
Introduction,
Dr. Ellen Klapper, MD, Medical Director, Transfusion Medicine, Cedars Sinai Medical Center, Clincal Professor Department of Pathology and Laboratory Medicine UCLA School of Medicine, Cedars Sinai Medical Center
Gary Stack, MD, PhD, Chief, Pathology and Laboratory Medicine Service, VA Connecticut Healthcare System
Antibody Persistence & Evanescence
Ross Fasano, MD, Divisions of Hematology/Oncology and Laboratory Medicine, Children's National Medical Center
Antibodies in Children with Sickle Cell Disease: Incidence & Clinical Consequences
George Garratty, PhD, FRCPath, Scientific Director, American Red Cross Blood Services
Replacing Serology with DNA-based Approaches: A Serologist's Opinion
S. Gerald Sandler, MD, Director, Transfusion Medicine/Professor of Medicine and Pathology, MedStar Georgetown University Hospital
Clinical Consequences of Hemolytic Transfusion Reactions: Morbidity & Mortality
Description
Molecular immunohematology is poised to address non-ABO hemolytic transfusion reactions including: the prevention of alloimmunization through "dry matching" of red cell transfusions by genotype only, antibody evanescence, and the appropriate support for rare blood group haplotypes in chronic transfusion and marrow transplantation, as in patients with sickle cell disease. This education session is designed to challenge the transfusion scientific community to think about the impact that molecular immunohematology has on complex problems in transfusion. How can red cell alloimmunization be curtailed? What advantages can be had by dry matching donor "liquid organs" to patients? How can blood group genotyping be used to improve the support of chronically transfused and transplanted patients? Join us for presentations and discussions at the leading edge of applications in molecular immunohematology.

Dr. Garratty and Dr. Stack did not consent to presentation capturing and recording.

LEARNER OUTCOMES:
  • Identify the specific needs of transfusion support for children with sickle cell disease.
  • Provide current information on red cell alloimmunization and antibody evanescence.
  • Review the concept of molecular "dry matching" for red cell transfusions.
  • Summarize the immune hazards of red cell transfusions.


CE CategoryCE Value
California Clinical Laboratory Personnel 1.5
California Nurse 1.8
Florida Laboratory Personnel 1.8
General Attendee 1.5
Physician 1.5
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.


Online Access
(Code: 9310-TCAM/9310-TC/9310-TCA/9310-TC)
Annual Meeting Attendee/AABB Member:$25 USD
Non-Attendee/AABB Member:$40 USD
Annual Meeting Attendee/Non AABB Member:$40 USD
Non-Attendee/Non AABB Member $50 USD - Your Price
Add to Shopping Cart
This session is a part of:
Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are
the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text
are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or
reproduction of any materials herein is strictly prohibited.